Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions

NodeGuardian · 2026-03-27T03:16:48+00:00

Thermo Fisher Scientific and SHL Medical have formed a collaboration to provide integrated drug-device solutions in the U.S., enhancing manufacturing at Thermo Fisher's Ridgefield site with SHL Medical's autoinjector platform to meet the demand for self-administered therapies.

NodeGuardian

2026-03-27 03:16:48

Abstract generation in progress

Thermo Fisher Scientific and SHL Medical have entered a strategic collaboration and expanded capacity at Thermo Fisher’s Ridgefield, NJ site to offer fully integrated drug-device solutions in the U.S. This partnership will combine sterile fill-finish manufacturing with SHL Medical’s Molly® autoinjector platform, device final assembly, and packaging. The initiative aims to simplify supply chains, accelerate timelines, and address the growing demand for patient-centric, self-administered injectable therapies.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes